OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Drug and Alcohol Abuse is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Greater loss of face and family honor values are associated with greater positive expectancies and substance abuse among Middle Eastern/Northern African U.S. college students	70
Assessment of liability to substance use disorder induced by two emerging stimulants, 4,4′-dimethylaminorex and escaline, in mice	43
Associations between college enrollment and trends in substance use among young adults in the US from 2015 to 2019	36
A case series examining the efficacy of gabapentin as a substitution therapy for the treatment of pregabalin use disorder	32
Alcohol use and drinking motives across five countries: a post-COVID-19 pandemic update	32
Factors associated with naloxone availability and dispensing through Michigan’s pharmacy standing order	30
Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention	28
Differential effects of moderate chronic ethanol consumption on neurobehavior, white matter glial protein expression, and mTOR pathway signaling with adolescent brain maturation	22
Impacts of the COVID-19 public health restrictions on substance use, mental health, and psychosocial functioning among individuals with alcohol use disorder	21
Childhood trauma, intraindividual reaction time variability, baseline respiratory sinus arrhythmia, and perceived relapse tendency among males with substance use disorders	19
Cigarette and e-cigarette use as a function of psychological distress following COVID-19 related university campus closures	19
Family history, childhood maltreatment, and adolescent binge drinking exert synergistic effects on delay discounting and future alcohol use	16
Uncertainty in overdose death reporting impedes the public health response	13
Elbasvir/grazoprevir for the treatment of hepatitis C virus infection in people with opioid use disorder	13
Tianeptine: a new frontier in surveillance and understanding through social media	13